Increased Patient Share of Prescription Costs Negatively Impacts Drug Treatment and Adherence
The cost of prescription drugs is a major topic of conversation amongst Migraineurs and other patients who need prescription medications. Even for those who have insurance that covers medications, the amount paid by the patient has increased to consume a disproportionate amount of patient income and has left many patients with difficult medical and financial choices to make. Part of this phenomenon is coverage limits that affect the number of doses of triptans that are covered per month, a number that has recently been decreasing.
A review of previous studies indicates that an increase in prescription drug cost sharing is associated with a decrease in drug spending and use of pharmacies; and for some chronic conditions, higher cost sharing is associated with greater use of expensive medical services (doctor appointments, emergency care, hospitalization, etc.), according to an article in the July 4, 2007, issue of JAMA.